Table 3 Clinical characteristics of patients with high and low CD8+CD122+ T cell levels
From: Circulating CD8+CD122+ T cells as a prognostic indicator of pancreatic cancer
Characteristic | High CD8+CD122+ T cell ratio | Low CD8+CD122+ T cell ratio | P-value |
|---|---|---|---|
Total number | 11 | 43 | Â |
Sex (%) | |||
 Male | 4(36) | 22 (51) | 0.38 |
 Female | 7(64) | 21(49) |  |
Age (years) | |||
 Mean ± SD | 62.7 ± 2.7 | 65.5 ± 1.4 | 0.50 |
 Range | 42–74 | 49–79 |  |
Diabetes mellitus (%) | |||
 Yes | 2 (18%) | 21 (49%) | 0.67 |
Serum albumin (g/dL) | |||
 Median | 3.8 | 4.7 | 0.72 |
 Range | 2.2–4.3 | 2.6–4.5 |  |
ECOG performance status (%) | |||
 0/1/2 | 5(45.5)/5(45.5)/1(1) | 26(61)/16(37)/1(2) | 0.45 |
1st line chemotherapy regimen (%) | |||
 S-IROX/mFFX/GnP | 1(9)/3(27)/7(64) | 1(2)/8(19) /34(79) | 0.43 |
T factor (%) | |||
 1/2/3/4 | 0/0/5(45)/6(55) | 1(2)/0/26(61)/16(37) | 0.54 |
CA19-9 level (U/mL) | |||
 Median | 1924 | 571 | 0.21 |
 Range | 45.2–81446 | 1.5–606320 |  |